Skip to main content
. 2015 Sep 11;5:13982. doi: 10.1038/srep13982

Figure 12. DGLHD decreased JAK2, STAT3 protein expression and increased SOCS3 level in the pancreas, spleen and thymus.

Figure 12

(A) Respectively western blot results showed the expressions of JAK2, STAT3, p-STAT3 and SOCS3 in 12 week-old NOD mice treated with DGLHD for 4 weeks from 8 until 12 weeks and model control group. β-actin was used as loading control. (B) Bar graphs showed semi-quantitative evaluation of their expression by densitometry. Data were presented as means ± SD (n = 3). *P < 0.05, **P < 0.01 compared with model control group.